This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Feb 26;350(9):913-22.

doi: 10.1056/NEJMra032207.

Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency

Matthew P McCormack¹, Terence H Rabbitts

Affiliations

PMID: 14985489
DOI: 10.1056/NEJMra032207

Review

Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency

Matthew P McCormack et al. N Engl J Med. 2004.

. 2004 Feb 26;350(9):913-22.

doi: 10.1056/NEJMra032207.

Authors

Matthew P McCormack¹, Terence H Rabbitts

Affiliation

¹ Rotary Bone Marrow Research Laboratory, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

PMID: 14985489
DOI: 10.1056/NEJMra032207

No abstract available

PubMed Disclaimer

Comment in

LMO2 and gene therapy for severe combined immunodeficiency.
Fischer A, Abina SH, Thrasher A, von Kalle C, Cavazzana-Calvo M. Fischer A, et al. N Engl J Med. 2004 Jun 10;350(24):2526-7; author reply 2526-7. doi: 10.1056/NEJM200406103502422. N Engl J Med. 2004. PMID: 15190153 No abstract available.
LMO2 and gene therapy for severe combined immunodeficiency.
Stone BD. Stone BD. N Engl J Med. 2004 Jun 10;350(24):2526-7; author reply 2526-7. N Engl J Med. 2004. PMID: 15195349 No abstract available.

Similar articles

LMO2 and gene therapy for severe combined immunodeficiency.
Fischer A, Abina SH, Thrasher A, von Kalle C, Cavazzana-Calvo M. Fischer A, et al. N Engl J Med. 2004 Jun 10;350(24):2526-7; author reply 2526-7. doi: 10.1056/NEJM200406103502422. N Engl J Med. 2004. PMID: 15190153 No abstract available.
Gene therapy insertional mutagenesis insights.
Davé UP, Jenkins NA, Copeland NG. Davé UP, et al. Science. 2004 Jan 16;303(5656):333. doi: 10.1126/science.1091667. Science. 2004. PMID: 14726584 No abstract available.
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M. Hacein-Bey-Abina S, et al. Science. 2003 Oct 17;302(5644):415-9. doi: 10.1126/science.1088547. Science. 2003. PMID: 14564000
Occurrence of leukaemia following gene therapy of X-linked SCID.
Kohn DB, Sadelain M, Glorioso JC. Kohn DB, et al. Nat Rev Cancer. 2003 Jul;3(7):477-88. doi: 10.1038/nrc1122. Nat Rev Cancer. 2003. PMID: 12835668 Review.
Genotoxicity of retroviral integration in hematopoietic cells.
Nienhuis AW, Dunbar CE, Sorrentino BP. Nienhuis AW, et al. Mol Ther. 2006 Jun;13(6):1031-49. doi: 10.1016/j.ymthe.2006.03.001. Epub 2006 Apr 19. Mol Ther. 2006. PMID: 16624621 Review.

See all similar articles

Cited by

Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling.
Hohwieler M, Illing A, Hermann PC, Mayer T, Stockmann M, Perkhofer L, Eiseler T, Antony JS, Müller M, Renz S, Kuo CC, Lin Q, Sendler M, Breunig M, Kleiderman SM, Lechel A, Zenker M, Leichsenring M, Rosendahl J, Zenke M, Sainz B Jr, Mayerle J, Costa IG, Seufferlein T, Kormann M, Wagner M, Liebau S, Kleger A. Hohwieler M, et al. Gut. 2017 Mar;66(3):473-486. doi: 10.1136/gutjnl-2016-312423. Epub 2016 Sep 15. Gut. 2017. PMID: 27633923 Free PMC article.
Identification of c-Myb Target Genes in K562 Cells Reveals a Role for c-Myb as a Master Regulator.
Lorenzo PI, Brendeford EM, Gilfillan S, Gavrilov AA, Leedsak M, Razin SV, Eskeland R, Sæther T, Gabrielsen OS. Lorenzo PI, et al. Genes Cancer. 2011 Aug;2(8):805-17. doi: 10.1177/1947601911428224. Genes Cancer. 2011. PMID: 22393465 Free PMC article.
High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia.
Wu L, Xu Y, Wang Q, Ruan C, Drexler HG, Wu D, MacLeod RA, Chen S. Wu L, et al. Haematologica. 2015 Jun;100(6):e233-6. doi: 10.3324/haematol.2014.120089. Epub 2015 Feb 14. Haematologica. 2015. PMID: 25682596 Free PMC article. No abstract available.
Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2.
Kauss MA, Smith LJ, Zhong L, Srivastava A, Wong KK Jr, Chatterjee S. Kauss MA, et al. Hum Gene Ther. 2010 Sep;21(9):1129-36. doi: 10.1089/hum.2010.016. Hum Gene Ther. 2010. PMID: 20486772 Free PMC article.
Homo-binding character of LMO2 isoforms and their both synergic and antagonistic functions in regulating hematopoietic-related target genes.
Sun W, Shen WW, Yang S, Hu F, Gao Y, Qiao YH, Zhu TH. Sun W, et al. J Biomed Sci. 2010 Mar 27;17(1):22. doi: 10.1186/1423-0127-17-22. J Biomed Sci. 2010. PMID: 20346173 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- Genetic Alliance
- MedlinePlus Health Information